Shoprite Holdings Limited
(Incorporated in the Republic of South Africa)
Registration Number: 1936/007721/06
ISIN: ZAE000012084
JSE share code: SHP
A2X share code: SHP
NSX share code: SRH
LUSE share code: SHOPRITE
(“Shoprite Holdings”)
DEALING IN SECURITIES BY AN ASSOCIATE OF A DIRECTOR
In compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited, shareholders are
advised that an associate of a director has effected the following dealings in Shoprite Holdings securities: an
on-market sale of ordinary shares, and entry into a scrip borrowing arrangement (the “Third Scrip Loan”).
In terms of paragraphs 3.63 to 3.74 of the Listings Requirements, the following information is disclosed:
Name of director: Dr CH Wiese
Designation: Non-executive Director
Associate: Titan Fincap Solutions (RF) (Pty) Ltd (“Titan Fincap”)
Date of transaction: 2 October 2025
Class of securities: Ordinary shares
Nature of transaction: On market sale of ordinary shares
Number of securities: 3,831,164
Price per security: R278.50
Total value: R1,066,979,174.00
Nature of interest for director: Indirect beneficial through Titan Fincap, controlled by
Titan Premier Investment (Pty) Ltd (“TPI”), of which
Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
Titan Fincap has entered into the Third Scrip Loan, the details of which are set out in the table below.
Name of director: Dr CH Wiese
Designation: Non-executive Director
Associate: Titan Fincap
Date of transaction: 3 October 2025
Class of securities: Ordinary shares
Nature of transaction: Scrip borrow of Shoprite Holdings ordinary shares by
Titan Fincap (on market)
Number of securities: 3,831,164
Deemed price per security: R278.50 (based on the sale price of Shoprite Holdings
ordinary shares referenced above)
Total value of the Transaction: R1,066,979,174.00
Nature of interest for director: Indirect beneficial through Titan Fincap controlled by TPI,
of which Dr CH Wiese is a director
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
Cape Town
6 October 2025
Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited